Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Ansa Biotechnologies Inc., the trusted partner for DNA synthesis, today announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer. Mr. Hamilton will report ...

North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

A new portable DNA test can identify dozens of shark and ray species in only two hours, giving frontline officers a powerful ...

Dallas-based Meros Investment Management purchased 159,945 shares of Azenta valued at $4.6 million in the third quarter. The position represents 2% of Meros’s 13F reportable assets under management.

Danaher companies Integrated DNA Technologies (IDT), a specialist in genomics, and Beckman Coulter Life Sciences, a ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...

Glaciers are flush with microbial life. But, as climate change speeds glacial melting, scientists rush to establish microbial ...

She worked on preparations for the second, third, and fourth shuttle missions, and was a Cape Crusader at the Kennedy Space ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...